Public-private partnerships (P3s) have become an increasingly pivotal—almost doctrinal—driver of R&D across the health sciences, allowing governments, academic institutions, not-for-profit organizations, care providers, investors and industry to leverage scarce resources and expertise, share risk, expand the field of viable innovation opportunities and, in theory, accelerate health and economic impact. Buoyed by their compelling logic, partnerships have flourished globally, and as their scope and diversity have expanded, so too has creative appetite to experiment with unorthodox models. But for all the advantages that have made P3s increasingly inevitable, these partnerships have not become less complex. Clarifying governance and decision-making, managing inconsistent perceptions of risk, enforcing ownership and accountability, aligning incentives, ensuring access to innovation: these are just a few of the considerations that distinguish success from failure. Shift Health, Canada’s premier strategy consultancy devoted to the HealthSphere, has enjoyed the privilege of working with cross-sector partnerships at the forefront of this R&D movement. This talk will share insights and perspectives on health innovation partnerships at the converging frontiers of private profit and public benefit.
Dr. Ryan Wiley is President of Shift Health. With extensive experience in corporate, R&D and innovation strategy, opportunity evaluation, implementation oversight, capacity-building and public-private partnerships, Ryan has successfully worked with multinational companies, governments, academic institutions, not-for-profit organizations and healthcare providers around the world to shift thinking about healthcare and life sciences strategy. Ryan has effectively facilitated and managed ground-breaking alliances that have opened new markets and leveraged hundreds of millions of dollars in investment, and he has worked seamlessly with the public and private sectors on system transformation, economic development, health research, global health and commercialization initiatives across North America, Latin America, Europe, Southeast Asia, Sub-Saharan Africa and the Middle East. Ryan is an Assistant Professor at McMaster University, Chair of Research Canada, Director of Amref Health Africa, Director of CanHealth International, member of McMaster’s Biomedical Discovery and Commercialization Programme Advisory Board, past Director of Women’s College Hospital Foundation and founding Co-chair of neWCHapter at Women’s College Hospital Foundation. Ryan holds a PhD in immunology from McMaster University and has published in the areas of asthma/allergy, pharmacology and gene therapy.